{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:49:54Z","timestamp":1740142194785,"version":"3.37.3"},"reference-count":164,"publisher":"Bentham Science Publishers Ltd.","issue":"20","funder":[{"DOI":"10.13039\/501100002969","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["TH02010345"],"award-info":[{"award-number":["TH02010345"]}],"id":[{"id":"10.13039\/501100002969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004578","name":"Ministry of Industry and Trade","doi-asserted-by":"publisher","award":["FV20572"],"award-info":[{"award-number":["FV20572"]}],"id":[{"id":"10.13039\/501100004578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education, Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["LM201564 (EATRIS-CZ)"],"award-info":[{"award-number":["LM201564 (EATRIS-CZ)"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"National Programme of Sustainability I - NPU I","doi-asserted-by":"publisher","award":["MSMT-43760\/2015"],"award-info":[{"award-number":["MSMT-43760\/2015"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Operational Programme Prague \u2013 Competitiveness","doi-asserted-by":"publisher","award":["CZ.2.16\/3.1.00\/21537"],"award-info":[{"award-number":["CZ.2.16\/3.1.00\/21537"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University in Prague","doi-asserted-by":"publisher","award":["UNCE 204011\/2012","PRVOUK P24\/LF1\/3"],"award-info":[{"award-number":["UNCE 204011\/2012","PRVOUK P24\/LF1\/3"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002969","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["TE01020028"],"award-info":[{"award-number":["TE01020028"]}],"id":[{"id":"10.13039\/501100002969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education, Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["BIOCEV-FAR LQ1604","CZ.1.05\/1.1.00\/02.0109"],"award-info":[{"award-number":["BIOCEV-FAR LQ1604","CZ.1.05\/1.1.00\/02.0109"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,9,13]]},"abstract":"<jats:sec><jats:title\/><jats:p>Filamentous ascomycetes (Neurospora and Monascus) have been studied for a long time because of their production of secondary metabolites such as microbial pigments. The ascomycetes represent an interesting group of compounds with high potential for medicinal applications. Many recent studies have shown their efficacy in the treatment of serious pathological states such as oncological diseases, neurodegenerative diseases and hyperlipidaemia. Nevertheless, the clinical usability of ascomycetes is still limited. However, this problem can be solved by the use of these compounds with combinations of other therapeutic agents. This strategy can suppress their side effects and improve their therapeutic efficacy. Moreover, their co-application can significantly enhance conventional therapies that are used. This review summarizes and discusses the general principles of this approach, introduced and supported by numerous examples. In addition, the prediction of the future potential application of this methodology is included.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867325666180330091933","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T12:02:27Z","timestamp":1522411347000},"page":"3812-3834","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pigments from Filamentous Ascomycetes for Combination Therapy"],"prefix":"10.2174","volume":"26","author":[{"given":"R\u00f3bert","family":"Hrom\u00e1dka","sequence":"first","affiliation":[{"name":"C2P s.r.o. Jungmannova 101 503 51 Chlumec nad Cidlinou, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zden\u011bk","family":"Kej\u00edk","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Jakubek","sequence":"additional","affiliation":[{"name":"BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kapl\u00e1nek","sequence":"additional","affiliation":[{"name":"BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viera","family":"\u0160andrikov\u00e1","sequence":"additional","affiliation":[{"name":"C2P s.r.o. Jungmannova 101 503 51 Chlumec nad Cidlinou, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Urban","sequence":"additional","affiliation":[{"name":"Food Research Institute Prague, Radiova 1285\/7, 1285\/7, Prague 10, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Mart\u00e1sek","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Kr\u00e1l","sequence":"additional","affiliation":[{"name":"BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40694-017-0033-2","volume":"4","author":"Gmoser R.","year":"2017","unstructured":"Gmoser R.; Ferreira J.A.; Lennartsson P.R.; Taherzadeh M.J.; Filamentous ascomycetes fungi as a source of natural pigments. Fungal Biol Biotechnol 2017,4(1),4","journal-title":"Fungal Biol Biotechnol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/026520399284280","volume":"16","author":"Mart\u00ednkov\u00e1 L.","year":"1999","unstructured":"Mart\u00ednkov\u00e1 L.; Pat\u00e1kov\u00e1-J\u016fzlov\u00e1 P.; Krent V.; Kucerov\u00e1 Z.; Havl\u00edcek V.; Olsovsk\u00fd P.; Hovorka O.; R\u00edhov\u00e1 B.; Vesel\u00fd D.; Vesel\u00e1 D.; Ulrichov\u00e1 J.; Prikrylov\u00e1 V.; Biological activities of oligoketide pigments of Monascus purpureus. Food Addit Contam 1999,16(1),15-24","journal-title":"Food Addit Contam"},{"year":"2015","key":"ref=3","unstructured":"Schreiberova, O., Ed.; Patrovsk\u00fd M. and P. P., Produkce sekund\u00e1rn\u00edch metabolit\u016f houbou Monascus purpureus, in 12. semin\u00e1\u0159 PIVOVARSTV\u00cd A KVASN\u00c9 TECHNOLOGIE 2015; Prague, Czech republic, 2015"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10295-012-1216-8","volume":"40","author":"Patakova P.","year":"2013","unstructured":"Patakova P.; Monascus secondary metabolites: production and biological activity. J Ind Microbiol Biotechnol 2013,40(2),169-181","journal-title":"J Ind Microbiol Biotechnol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-61779-918-1_18","volume":"898","author":"Avalos J.","year":"2012","unstructured":"Avalos J.; Prado-Cabrero A.; Estrada A.F.; Neurosporaxanthin production by Neurospora and Fusarium. Methods Mol Biol 2012,898,263-274","journal-title":"Methods Mol Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1016\/j.phytochem.2008.09.016","volume":"69","author":"Sandmann G.","year":"2008","unstructured":"Sandmann G.; Takaichi S.; Fraser P.D.C.; (35)-apocarotenoids in the yellow mutant Neurospora crassa YLO. Phytochemistry 2008,69(17),2886-2890","journal-title":"Phytochemistry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11427-015-4836-1","volume":"58","author":"Xu N.","year":"2015","unstructured":"Xu N.; Shen N.; Wang X.; Jiang S.; Xue B.; Li C.; Protein prenylation and human diseases: a balance of protein farnesylation and geranylgeranylation. Sci China Life Sci 2015,58(4),328-335","journal-title":"Sci China Life Sci"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071583","volume":"18","author":"Thapa A.","year":"2017","unstructured":"Thapa A.; Carroll N.J.; Dietary modulation of oxidative stress in alzheimer\u2019s disease. Int J Mol Sci 2017,18(7)","journal-title":"Int J Mol Sci"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3945\/an.116.014423","volume":"8","author":"Limon-Miro A.T.","year":"2017","unstructured":"Limon-Miro A.T.; Lopez-Teros V.; Astiazaran-Garcia H.; Dietary guidelines for breast cancer patients: a critical review. Adv Nutr 2017,8(4),613-623","journal-title":"Adv Nutr"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1177\/1535370216657900","volume":"241","author":"Wu L.","year":"2016","unstructured":"Wu L.; Guo X.; Wang W.; Medeiros D.M.; Clarke S.L.; Lucas E.A.; Smith B.J.; Lin D.; Molecular aspects of \u03b2, \u03b2-carotene-9\u2032, 10\u2032-oxygenase 2 in carotenoid metabolism and diseases. Exp Biol Med (Maywood) 2016,241(17),1879-1887","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/978-3-319-39126-7_15","volume":"79","author":"Bonet M.L.","year":"2016","unstructured":"Bonet M.L.; Canas J.A.; Ribot J.; Palou A.; Carotenoids in adipose tissue biology and obesity. Subcell Biochem 2016,79,377-414","journal-title":"Subcell Biochem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/ijpvm.IJPVM_112_17","volume":"8","author":"Bahonar A.","year":"2017","unstructured":"Bahonar A.; Saadatnia M.; Khorvash F.; Maracy M.; Khosravi A.; Carotenoids as potential antioxidant agents in stroke prevention: a systematic review. Int J Prev Med 2017,8,70","journal-title":"Int J Prev Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1016\/j.bmcl.2011.06.101","volume":"21","author":"Kej\u00edk Z.","year":"2011","unstructured":"Kej\u00edk Z.; B\u0159\u00edza T.; Kr\u00e1lov\u00e1 J.; Pou\u010dkov\u00e1 P.; Kr\u00e1l A.; Mart\u00e1sek P.; Kr\u00e1l V.; Coordination conjugates of therapeutic proteins with drug carriers: a new approach for versatile advanced drug delivery. Bioorg Med Chem Lett 2011,21(18),5514-5520","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1021\/jm9007278","volume":"53","author":"Kr\u00e1lov\u00e1 J.","year":"2010","unstructured":"Kr\u00e1lov\u00e1 J.; Kej\u00edk Z.; Br\u00edza T.; Pouckov\u00e1 P.; Kr\u00e1l A.; Mart\u00e1sek P.; Kr\u00e1l V.; Porphyrin-cyclodextrin conjugates as a nanosystem for versatile drug delivery and multimodal cancer therapy. J Med Chem 2010,53(1),128-138","journal-title":"J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.1016\/j.jconrel.2008.09.016","volume":"132","author":"Kejik Z.","year":"2008","unstructured":"Kejik Z.; Cyclodextrin dimer with porphyrin core for target transport and combined therapy. J Control Release 2008,132(3),E27-E28","journal-title":"J Control Release"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1039\/c002823a","volume":"8","author":"Z\u00e1ruba K.","year":"2010","unstructured":"Z\u00e1ruba K.; Kr\u00e1lov\u00e1 J.; Rezanka P.; Pouckov\u00e1 P.; Veverkov\u00e1 L.; Kr\u00e1l V.; Modified porphyrin-brucine conjugated to gold nanoparticles and their application in photodynamic therapy. Org Biomol Chem 2010,8(14),3202-3206","journal-title":"Org Biomol Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40292-017-0242-z","volume":"25","author":"Tocci G.","year":"2018","unstructured":"Tocci G.; How to improve effectiveness and adherence to antihypertensive drug therapy: central role of dihydropyridinic calcium channel blockers in hypertension. High Blood Press Cardiovasc Prev 2018,25(1),25-34","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/iub.1696","volume":"69","author":"Bhattacharjee S.","year":"2017","unstructured":"Bhattacharjee S.; Nandi S.; Synthetic lethality in DNA repair network: a novel avenue in targeted cancer therapy and combination therapeutics. IUBMB Life 2017,69(12),929-937","journal-title":"IUBMB Life"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.3390\/ijms18122504","volume":"18","author":"Gugliandolo A.","year":"2017","unstructured":"Gugliandolo A.; Bramanti P.; Mazzon E.; Role of Vitamin E in the treatment of Alzheimer\u2019s Disease: evidence from animal models. Int J Mol Sci 2017,18(12),2504","journal-title":"Int J Mol Sci"},{"key":"ref=20","volume":"18","author":"Matsunaga S.","year":"2014","unstructured":"Matsunaga S.; Kishi T.; Iwata N.; Combination therapy with cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a systematic review and meta-analysis. Int J Neuropsychopharmacol 2014,18(5)","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.clinthera.2017.10.013","volume":"39","author":"Lee H-Y.","year":"2017","unstructured":"Lee H-Y.; Kim S.Y.; Choi K.J.; Yoo B.S.; Cha D.H.; Jung H.O.; Ryu D.R.; Choi J.H.; Lee K.J.; Park T.H.; Oh J.H.; Kim S.M.; Choi J.Y.; Kim K.H.; Shim J.; Kim W.S.; Choi S.W.; Park D.G.; Song P.S.; Hong T.J.; Rhee M.Y.; Rha S.W.; Park S.W.A.; Randomized, multicenter, double-blind, placebo-controlled study to evaluate the efficacy and the tolerability of a triple combination of amlodipine\/losartan\/rosuvastatin in patients with comorbid essential hypertension and hyperlipidemia. Clin Ther 2017,39(12),2366-2379","journal-title":"Clin Ther"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1080\/03007995.2017.1367275","volume":"33","author":"Simons L.A.","year":"2017","unstructured":"Simons L.A.; Chung E.; Ortiz M.; Long-term persistence with single-pill, fixed-dose combination therapy versus two pills of amlodipine and perindopril for hypertension: Australian experience. Curr Med Res Opin 2017,33(10),1783-1787","journal-title":"Curr Med Res Opin"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147626","volume":"11","author":"Herrando-Grabulosa M.","year":"2016","unstructured":"Herrando-Grabulosa M.; Mulet R.; Pujol A.; Mas J.M.; Navarro X.; Aloy P.; Coma M.; Casas C.; Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems. PLoS One 2016,11(1)","journal-title":"PLoS One"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/10610278.2011.631705","volume":"24","author":"Kejik Z.","year":"2012","unstructured":"Kejik Z.; Supramolecular approach for target transport of photodynamic anticancer agents. Supramol Chem 2012,24(2),106-116","journal-title":"Supramol Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ejmech.2017.06.017","volume":"138","author":"Brogi S.","year":"2017","unstructured":"Brogi S.; Ramunno A.; Savi L.; Chemi G.; Alfano G.; Pecorelli A.; Pambianchi E.; Galatello P.; Compagnoni G.; Focher F.; Biamonti G.; Valacchi G.; Butini S.; Gemma S.; Campiani G.; Brindisi M.; First dual AK\/GSK-3\u03b2 inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents. Eur J Med Chem 2017,138,438-457","journal-title":"Eur J Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bmc.2017.12.041","volume":"26","author":"Liu J.","year":"2018","unstructured":"Liu J.; Qian C.; Zhu Y.; Cai J.; He Y.; Li J.; Wang T.; Zhu H.; Li Z.; Li W.; Hu L.; Design, Synthesis and Evaluate of novel dual FGFR1 and HDAC inhibitors bearing an indazole scaffold. Bioorg Med Chem 2018,26(3),747-757","journal-title":"Bioorg Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.bmc.2017.12.020","volume":"26","author":"Monastyrskyi A.","year":"2018","unstructured":"Monastyrskyi A.; Nilchan N.; Quereda V.; Noguchi Y.; Ruiz C.; Grant W.; Cameron M.; Duckett D.; Roush W.; Development of dual casein kinase 1\u03b4\/1\u03b5 (CK1\u03b4\/\u03b5) inhibitors for treatment of breast cancer. Bioorg Med Chem 2018,26(3),590-602","journal-title":"Bioorg Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1016\/j.bmc.2017.10.017","volume":"25","author":"Chen W.","year":"2017","unstructured":"Chen W.; Huang Z.; Wang W.; Mao F.; Guan L.; Tang Y.; Jiang H.; Li J.; Huang J.; Jiang L.; Zhu J.; Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely. Bioorg Med Chem 2017,25(24),6467-6478","journal-title":"Bioorg Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.bmcl.2017.02.008","volume":"27","author":"Wang C.","year":"2017","unstructured":"Wang C.; Yang D.; Jiang L.; Wang S.; Wang J.; Zhou K.; Shi X.; Chang L.; Liu Y.; Ke Y.; Liu H.; Jesridonin in combination with paclitaxel demonstrates synergistic anti-tumor activity in human esophageal carcinoma cells. Bioorg Med Chem Lett 2017,27(9),2058-2062","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.bmc.2017.01.043","volume":"25","author":"Tunc D.","year":"2017","unstructured":"Tunc D.; Dere E.; Karakas D.; Cevatemre B.; Yilmaz V.T.; Ulukaya E.; Cytotoxic and apoptotic effects of the combination of palladium (II) 5,5-diethylbarbiturate complex with bis(2-pyridylmethyl)amine and curcumin on non small lung cancer cell lines. Bioorg Med Chem 2017,25(5),1717-1723","journal-title":"Bioorg Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.bmcl.2015.12.010","volume":"26","author":"Byun J.S.","year":"2016","unstructured":"Byun J.S.; Sohn J.M.; Leem D.G.; Park B.; Nam J.H.; Shin D.H.; Shin J.S.; Kim H.J.; Lee K.T.; Lee J.Y.; In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells. Bioorg Med Chem Lett 2016,26(3),1073-1079","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/ar.23525","volume":"300","author":"Bayomy N.A.","year":"2017","unstructured":"Bayomy N.A.; Elbakary R.H.; Ibrahim M.A.A.; Abdelaziz E.Z.; Effect of lycopene and rosmarinic acid on gentamicin induced renal cortical oxidative stress, apoptosis, and autophagy in adult male albino rat. Anat Rec (Hoboken) 2017,300(6),1137-1149","journal-title":"Anat Rec (Hoboken)"},{"key":"ref=33","first-page":"430","volume":"41","author":"Kumar V.","year":"2016","unstructured":"Kumar V.; Sharma S.K.; Nagarajan K.; Dixit P.K.; Effects of lycopene and sodium valproate on pentylenetetrazol-induced kindling in mice. Iran J Med Sci 2016,41(5),430-436","journal-title":"Iran J Med Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jtemb.2013.01.001","volume":"27","author":"Banji D.","year":"2013","unstructured":"Banji D.; Banji O.J.; Reddy M.; Annamalai A.R.; Impact of zinc, selenium and lycopene on capsaicin induced mutagenicity and oxidative damage in mice. J Trace Elem Med Biol 2013,27(3),230-235","journal-title":"J Trace Elem Med Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"23857","DOI":"10.18632\/oncotarget.4408","volume":"6","author":"Yang S.H.","year":"2015","unstructured":"Yang S.H.; Lin H.Y.; Chang V.H.; Chen C.C.; Liu Y.R.; Wang J.; Zhang K.; Jiang X.; Yen Y.; Lovastatin overcomes gefitinib resistance through TNF-\u03b1 signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo. Oncotarget 2015,6(27),23857-23873","journal-title":"Oncotarget"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s11745-007-3102-0","volume":"42","author":"Wali V.B.","year":"2007","unstructured":"Wali V.B.; Sylvester P.W.; Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells. Lipids 2007,42(12),1113-1123","journal-title":"Lipids"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1124\/jpet.106.116467","volume":"322","author":"Roelofs A.J.","year":"2007","unstructured":"Roelofs A.J.; Edwards C.M.; Russell R.G.; Ebetino F.H.; Rogers M.J.; Hulley P.A.; Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Pharmacol Exp Ther 2007,322(1),228-235","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10637-009-9319-4","volume":"28","author":"Park I.H.","year":"2010","unstructured":"Park I.H.; Kim J.Y.; Jung J.I.; Han J.Y.; Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations. Invest New Drugs 2010,28(6),791-799","journal-title":"Invest New Drugs"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1158\/1078-0432.CCR-04-1951","volume":"11","author":"Mantha A.J.","year":"2005","unstructured":"Mantha A.J.; Hanson J.E.; Goss G.; Lagarde A.E.; Lorimer I.A.; Dimitroulakos J.; Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor. Clin Cancer Res 2005,11(6),2398-2407","journal-title":"Clin Cancer Res"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171157","volume":"12","author":"Liu P.C.","year":"2017","unstructured":"Liu P.C.; Inhibition of NF-kappa B Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy. PLoS One 2017,12(1)","journal-title":"PLoS One"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040462","volume":"7","author":"Chiu H.W.","year":"2012","unstructured":"Chiu H.W.; Fang W.H.; Chen Y.L.; Wu M.D.; Yuan G.F.; Ho S.Y.; Wang Y.J.; Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy. PLoS One 2012,7(7)","journal-title":"PLoS One"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1021\/jf3016927","volume":"60","author":"Chen R.J.","year":"2012","unstructured":"Chen R.J.; Hung C.M.; Chen Y.L.; Wu M.D.; Yuan G.F.; Wang Y.J.; Monascuspiloin induces apoptosis and autophagic cell death in human prostate cancer cells via the Akt and AMPK signaling pathways. J Agric Food Chem 2012,60(29),7185-7193","journal-title":"J Agric Food Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1016\/j.freeradbiomed.2012.08.243","volume":"53","author":"Chen R.J.","year":"2012","unstructured":"Chen R.J.; Monascuspiloin: A monascin analogue induces apoptosis and autophagic cell death in human prostate cancer cells via the Akt and AMPK signaling pathways. Free Radic Biol Med 2012,53,S116-S117","journal-title":"Free Radic Biol Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/ijc.10119","volume":"97","author":"Giermasz A.","year":"2002","unstructured":"Giermasz A.; Makowski M.; Koz\u0142owska E.; Nowis D.; Maj M.; Jalili A.; Feleszko W.; W\u00f3jcik C.; Dabrowska A.; Jak\u00f3bisiak M.; Go\u0142ab J.; Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice. Int J Cancer 2002,97(6),746-750","journal-title":"Int J Cancer"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11060-008-9627-0","volume":"90","author":"Cemeus C.","year":"2008","unstructured":"Cemeus C.; Zhao T.T.; Barrett G.M.; Lorimer I.A.; Dimitroulakos J.; Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status. J Neurooncol 2008,90(1),9-17","journal-title":"J Neurooncol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.toxlet.2016.08.010","volume":"261","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y.; Zhu X.; Huang T.; Chen L.; Liu Y.; Li Q.; Song J.; Ma S.; Zhang K.; Yang B.; Guan F.; \u03b2-Carotene synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal squamous cell carcinoma in vivo and in vitro. Toxicol Lett 2016,261,49-58","journal-title":"Toxicol Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3892\/or.19.5.1205","volume":"19","author":"Rozados V.R.","year":"2008","unstructured":"Rozados V.R.; Hinrichsen L.I.; Binda M.M.; Gervasoni S.I.; Matar P.; Bonfil R.D.; Scharovsky O.G.; Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models. Oncol Rep 2008,19(5),1205-1211","journal-title":"Oncol Rep"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/cncr.26336","volume":"118","author":"Moriceau G.","year":"2012","unstructured":"Moriceau G.; Roelofs A.J.; Brion R.; Redini F.; Ebetion F.H.; Rogers M.J.; Heymann D.; Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth. Cancer 2012,118(3),750-760","journal-title":"Cancer"},{"key":"ref=49","first-page":"523","volume":"232","author":"McAnally J.A.","year":"2007","unstructured":"McAnally J.A.; Gupta J.; Sodhani S.; Bravo L.; Mo H.; Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp Biol Med (Maywood) 2007,232(4),523-531","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00277-011-1276-2","volume":"90","author":"Hus M.","year":"2011","unstructured":"Hus M.; Grzasko N.; Szostek M.; Pluta A.; Helbig G.; Woszczyk D.; Adamczyk-Cioch M.; Jawniak D.; Legiec W.; Morawska M.; Kozinska J.; Waci\u0144ski P.; Dmoszynska A.; Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma. Ann Hematol 2011,90(10),1161-1166","journal-title":"Ann Hematol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/glia.20745","volume":"57","author":"Paintlia A.S.","year":"2009","unstructured":"Paintlia A.S.; Paintlia M.K.; Singh I.; Skoff R.B.; Singh A.K.; Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis. Glia 2009,57(2),182-193","journal-title":"Glia"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.2353\/ajpath.2006.051309","volume":"169","author":"Paintlia A.S.","year":"2006","unstructured":"Paintlia A.S.; Paintlia M.K.; Singh I.; Singh A.K.; Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis. Am J Pathol 2006,169(3),1012-1025","journal-title":"Am J Pathol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.expneurol.2008.07.024","volume":"214","author":"Paintlia A.S.","year":"2008","unstructured":"Paintlia A.S.; Paintlia M.K.; Singh I.; Singh A.K.; Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis. Exp Neurol 2008,214(2),168-180","journal-title":"Exp Neurol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4172\/2155-9899.1000149","volume":"4","author":"Paintlia A.S.","year":"2013","unstructured":"Paintlia A.S.; Mohan S.; Singh I.; Combinatorial effect of metformin and lovastatin impedes T-cell autoimmunity and neurodegeneration in experimental autoimmune encephalomyelitis. J Clin Cell Immunol 2013,4,4","journal-title":"J Clin Cell Immunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0026-0495(99)90009-4","volume":"48","author":"Zamb\u00f3n D.","year":"1999","unstructured":"Zamb\u00f3n D.; Ros E.; Rodriguez-Villar C.; Laguna J.C.; V\u00e1zquez M.; Sanllehy C.; Casals E.; Sol J.M.; Hern\u00e1ndez G.; Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation. Metabolism 1999,48(1),47-54","journal-title":"Metabolism"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/clc.4960260304","volume":"26","author":"Hunninghake D.B.","year":"2003","unstructured":"Hunninghake D.B.; McGovern M.E.; Koren M.; Brazg R.; Murdock D.; Weiss S.; Pearson T.; A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and lovastatin. Clin Cardiol 2003,26(3),112-118","journal-title":"Clin Cardiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0002-9149(01)02338-4","volume":"89","author":"Kashyap M.L.","year":"2002","unstructured":"Kashyap M.L.; McGovern M.E.; Berra K.; Guyton J.R.; Kwiterovich P.O.; Harper W.L.; Toth P.D.; Favrot L.K.; Kerzner B.; Nash S.D.; Bays H.E.; Simmons P.D.; Long-term safety and efficacy of a once-daily niacin\/lovastatin formulation for patients with dyslipidemia. Am J Cardiol 2002,89(6),672-678","journal-title":"Am J Cardiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archinte.164.10.1121","volume":"164","author":"Insull W.","year":"2004","unstructured":"Insull W.; McGovern M.E.; Schrott H.; Thompson P.; Crouse J.R.; Zieve F.; Corbelli J.; Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis. Arch Intern Med 2004,164(10),1121-1127","journal-title":"Arch Intern Med"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/clc.4960240610","volume":"24","author":"Davidson M.H.","year":"2001","unstructured":"Davidson M.H.; Toth P.; Weiss S.; McKenney J.; Hunninghake D.; Isaacsohn J.; Donovan J.M.; Burke S.K.; Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Clin Cardiol 2001,24(6),467-474","journal-title":"Clin Cardiol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/S0167-5273(97)00243-X","volume":"62","author":"Orekhov A.N.","year":"1997","unstructured":"Orekhov A.N.; Tertov V.V.; Sobenin I.A.; Akhmedzhanov N.M.; Pivovarova E.M.; Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin. Int J Cardiol 1997,62(Suppl. 2),S67-S77","journal-title":"Int J Cardiol"},{"key":"ref=61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040332","volume":"18","author":"Assis R.P.","year":"2017","unstructured":"Assis R.P.; Arcaro C.A.; Gutierres V.O.; Oliveira J.O.; Costa P.I.; Baviera A.M.; Brunetti I.L.; Combined Effects of Curcumin and Lycopene or Bixin in Yoghurt on inhibition of LDL Oxidation and increases in HDL and paraoxonase levels in streptozotocin-diabetic rats. Int J Mol Sci 2017,18(4)","journal-title":"Int J Mol Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","volume":"240","author":"Gerards M.C.","year":"2015","unstructured":"Gerards M.C.; Terlou R.J.; Yu H.; Koks C.H.; Gerdes V.E.; Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis. Atherosclerosis 2015,240(2),415-423","journal-title":"Atherosclerosis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jacl.2012.09.003","volume":"7","author":"Childress L.","year":"2013","unstructured":"Childress L.; Gay A.; Zargar A.; Ito M.K.; Review of red yeast rice content and current Food and Drug Administration oversight. J Clin Lipidol 2013,7(2),117-122","journal-title":"J Clin Lipidol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/01.NAJ.0000521973.38717.2e","volume":"117","author":"Peng D.","year":"2017","unstructured":"Peng D.; Fong A.; Pelt A.V.; Original research: The effects of red yeast rice supplementation on cholesterol levels in adults. Am J Nurs 2017,117(8),46-54","journal-title":"Am J Nurs"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/s13197-013-1191-8","volume":"52","author":"Rajasekaran A.","year":"2015","unstructured":"Rajasekaran A.; Kalaivani M.; Protective effect of Monascus fermented rice against STZ-induced diabetic oxidative stress in kidney of rats. J Food Sci Technol 2015,52(3),1434-1443","journal-title":"J Food Sci Technol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.foodchem.2015.10.124","volume":"197","author":"Handa C.L.","year":"2016","unstructured":"Handa C.L.; de Lima F.S.; Guelfi M.F.; Georgetti S.R.; Ida E.I.; Multi-response optimisation of the extraction solvent system for phenolics and antioxidant activities from fermented soy flour using a simplex-centroid design. Food Chem 2016,197(Pt A),175-184","journal-title":"Food Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3109\/13880209.2015.1104698","volume":"54","author":"Tseng W.T.","year":"2016","unstructured":"Tseng W.T.; Hsu Y.W.; Pan T.M.; Neuroprotective effects of dimerumic acid and deferricoprogen from Monascus purpureus NTU 568-fermented rice against 6-hydroxydopamine-induced oxidative stress and apoptosis in differentiated pheochromocytoma PC-12 cells. Pharm Biol 2016,54(8),1434-1444","journal-title":"Pharm Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1039\/C5FO00976F","volume":"7","author":"Tseng W.T.","year":"2016","unstructured":"Tseng W.T.; Hsu Y.W.; Pan T.M.; The ameliorative effect of Monascus purpureus NTU 568-fermented rice extracts on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and the rat model of Parkinson\u2019s disease. Food Funct 2016,7(2),752-762","journal-title":"Food Funct"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1021\/acs.jafc.6b02779","volume":"64","author":"Shi Y.C.","year":"2016","unstructured":"Shi Y.C.; Pan T.M.; Liao V.H.; Monascin from monascus-fermented products reduces oxidative stress and amyloid-\u03b2 toxicity via DAF-16\/FOXO in Caenorhabditis elegans. J Agric Food Chem 2016,64(38),7114-7120","journal-title":"J Agric Food Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.foodchem.2013.02.110","volume":"141","author":"Pyo Y.H.","year":"2013","unstructured":"Pyo Y.H.; Seong K.S.; Effects of Monascus-fermented grain extracts on plasma antioxidant status and tissue levels of ubiquinones and \u03b1-tocopherol in hyperlipidemic rats. Food Chem 2013,141(1),428-435","journal-title":"Food Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jbiosc.2012.11.003","volume":"115","author":"Huang C.S.","year":"2013","unstructured":"Huang C.S.; Hu H.H.; Tsai Y.M.; Chang W.T.; In vitro effects of Monascus purpureus on antioxidation activity during fermentation of Kinmen sorghum liquor waste. J Biosci Bioeng 2013,115(4),418-423","journal-title":"J Biosci Bioeng"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s13197-012-0618-y","volume":"51","author":"Wang P.","year":"2014","unstructured":"Wang P.; Chen D.; Jiang D.; Dong X.; Chen P.; Lin Y.; Alkali extraction and in vitro antioxidant activity of Monascus mycelium polysaccharides. J Food Sci Technol 2014,51(7),1251-1259","journal-title":"J Food Sci Technol"},{"key":"ref=73","author":"Hromadka R.","year":"2016","unstructured":"Hromadka R.; Example of successful industrial partnership with Charles University and Academy of Science of Czech Republic in Collaboration of academic and application sphere 2016","journal-title":"Example of successful industrial partnership with Charles University and Academy of Science of Czech Republic in Collaboration of academic and application sphere"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00277-016-2898-1","volume":"96","author":"Chen F.","year":"2017","unstructured":"Chen F.; Hu J.; Liu P.; Li J.; Wei Z.; Liu P.; Carotenoid intake and risk of non-Hodgkin lymphoma: a systematic review and dose-response meta-analysis of observational studies. Ann Hematol 2017,96(6),957-965","journal-title":"Ann Hematol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1080\/09637486.2016.1197892","volume":"67","author":"Chen J.","year":"2016","unstructured":"Chen J.; Jiang W.; Shao L.; Zhong D.; Wu Y.; Cai J.; Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis. Int J Food Sci Nutr 2016,67(7),744-753","journal-title":"Int J Food Sci Nutr"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/hsz-2014-0194","volume":"396","author":"Murai T.","year":"2015","unstructured":"Murai T.; Cholesterol lowering: role in cancer prevention and treatment. Biol Chem 2015,396(1),1-11","journal-title":"Biol Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1200\/JCO.2016.68.3482","volume":"34","author":"Sanfilippo K.M.","year":"2016","unstructured":"Sanfilippo K.M.; Keller J.; Gage B.F.; Luo S.; Wang T.F.; Moskowitz G.; Gumbel J.; Blue B.; O\u2019Brian K.; Carson K.R.; Statins Are Associated With Reduced Mortality in Multiple Myeloma. J Clin Oncol 2016,34(33),4008-4014","journal-title":"J Clin Oncol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1172\/JCI200519935","volume":"115","author":"Zhuang L.","year":"2005","unstructured":"Zhuang L.; Kim J.; Adam R.M.; Solomon K.R.; Freeman M.R.; Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 2005,115(4),959-968","journal-title":"J Clin Invest"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pharmthera.2014.02.007","volume":"143","author":"Yeganeh B.","year":"2014","unstructured":"Yeganeh B.; Wiechec E.; Ande S.R.; Sharma P.; Moghadam A.R.; Post M.; Freed D.H.; Hashemi M.; Shojaei S.; Zeki A.A.; Ghavami S.; Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther 2014,143(1),87-110","journal-title":"Pharmacol Ther"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1874467209666160112123205","volume":"10","author":"Bathaie S.Z.","year":"2017","unstructured":"Bathaie S.Z.; Ashrafi M.; Azizian M.; Tamanoi F.; Mevalonate pathway and human cancers. Curr Mol Pharmacol 2017,10(2),77-85","journal-title":"Curr Mol Pharmacol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0092-8674(94)90308-5","volume":"77","author":"Gibbs J.B.","year":"1994","unstructured":"Gibbs J.B.; Oliff A.; Kohl N.E.; Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 1994,77(2),175-178","journal-title":"Cell"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/nprot.2011.387","volume":"6","author":"Berndt N.","year":"2011","unstructured":"Berndt N.; Sebti S.M.; Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors. Nat Protoc 2011,6(11),1775-1791","journal-title":"Nat Protoc"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/s11658-006-0050-2","volume":"12","author":"Wei N.","year":"2007","unstructured":"Wei N.; Mi M.T.; Zhou Y.; Influences of lovastatin on membrane ion flow and intracellular signaling in breast cancer cells. Cell Mol Biol Lett 2007,12(1),1-15","journal-title":"Cell Mol Biol Lett"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbrc.2009.07.057","volume":"387","author":"Khaidakov M.","year":"2009","unstructured":"Khaidakov M.; Wang W.; Khan J.A.; Kang B.Y.; Hermonat P.L.; Mehta J.L.; Statins and angiogenesis: is it about connections? Biochem Biophys Res Commun 2009,387(3),543-547","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1007\/s13277-015-3551-7","volume":"36","author":"Matusewicz L.","year":"2015","unstructured":"Matusewicz L.; Meissner J.; Toporkiewicz M.; Sikorski A.F.; The effect of statins on cancer cells--review. Tumour Biol 2015,36(7),4889-4904","journal-title":"Tumour Biol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/j.cellsig.2015.07.014","volume":"27","author":"Chen C.C.","year":"2015","unstructured":"Chen C.C.; Liu T.Y.; Huang S.P.; Ho C.T.; Huang T.C.; Differentiation and apoptosis induction by lovastatin and \u03b3-tocotrienol in HL-60 cells via Ras\/ERK\/NF-\u03baB and Ras\/Akt\/NF-\u03baB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase. Cell Signal 2015,27(11),2182-2190","journal-title":"Cell Signal"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1378\/chest.08-0978","volume":"136","author":"Detterbeck F.C.","year":"2009","unstructured":"Detterbeck F.C.; Boffa D.J.; Tanoue L.T.; The new lung cancer staging system. Chest 2009,136(1),260-271","journal-title":"Chest"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"Molina J.R.","year":"2008","unstructured":"Molina J.R.; Yang P.; Cassivi S.D.; Schild S.E.; Adjei A.A.; Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008,83(5),584-594","journal-title":"Mayo Clin Proc"},{"key":"ref=89","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317705340","volume":"39","author":"Cui S.","year":"2017","unstructured":"Cui S.; Jiang L.; Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Tumour Biol 2017,39(5)","journal-title":"Tumour Biol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jhep.2014.03.033","volume":"61","author":"Clap\u00e9ron A.","year":"2014","unstructured":"Clap\u00e9ron A.; Mergey M.; Nguyen Ho-Bouldoires T.H.; Vignjevic D.; Wendum D.; Chr\u00e9tien Y.; Merabtene F.; Frazao A.; Paradis V.; Housset C.; Guedj N.; Fouassier L.; EGF\/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. J Hepatol 2014,61(2),325-332","journal-title":"J Hepatol"},{"key":"ref=91","first-page":"5251","volume":"32","author":"Nakajima Y.","year":"2012","unstructured":"Nakajima Y.; Takagi H.; Kakizaki S.; Horiguchi N.; Sato K.; Sunaga N.; Mori M.; Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells. Anticancer Res 2012,32(12),5251-5262","journal-title":"Anticancer Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"Razumilava N.","year":"2014","unstructured":"Razumilava N.; Gores G.J.; Cholangiocarcinoma. Lancet 2014,383(9935),2168-2179","journal-title":"Lancet"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1172\/JCI119812","volume":"100","author":"Pahan K.","year":"1997","unstructured":"Pahan K.; Sheikh F.G.; Namboodiri A.M.; Singh I.; Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 1997,100(11),2671-2679","journal-title":"J Clin Invest"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.expneurol.2017.09.006","volume":"299","author":"Daher A.","year":"2018","unstructured":"Daher A.; de Groot J.; Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model. Exp Neurol 2018,299(Pt B),281-288","journal-title":"Exp Neurol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/jnci\/93.16.1246","volume":"93","author":"Smith J.S.","year":"2001","unstructured":"Smith J.S.; Tachibana I.; Passe S.M.; Huntley B.K.; Borell T.J.; Iturria N.; O\u2019Fallon J.R.; Schaefer P.L.; Scheithauer B.W.; James C.D.; Buckner J.C.; Jenkins R.B.; PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 2001,93(16),1246-1256","journal-title":"J Natl Cancer Inst"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1038\/sj.onc.1206388","volume":"22","author":"Bianco R.","year":"2003","unstructured":"Bianco R.; Shin I.; Ritter C.A.; Yakes F.M.; Basso A.; Rosen N.; Tsurutani J.; Dennis P.A.; Mills G.B.; Arteaga C.L.; Loss of PTEN\/MMAC1\/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors. Oncogene 2003,22(18),2812-2822","journal-title":"Oncogene"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1365-2990.2010.01069.x","volume":"36","author":"Kuijlen J.M.","year":"2010","unstructured":"Kuijlen J.M.; Bremer E.; Mooij J.J.; den Dunnen W.F.; Helfrich W.; Review: on TRAIL for malignant glioma therapy? Neuropathol Appl Neurobiol 2010,36(3),168-182","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"8929","DOI":"10.1016\/S0021-9258(18)68397-8","volume":"263","author":"Nakanishi M.","year":"1988","unstructured":"Nakanishi M.; Goldstein J.L.; Brown M.S.; Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J Biol Chem 1988,263(18),8929-8937","journal-title":"J Biol Chem"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/153537020422900701","volume":"229","author":"Mo H.","year":"2004","unstructured":"Mo H.; Elson C.E.; Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 2004,229(7),567-585","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=100","first-page":"4937","volume":"30","author":"Fernandes N.V.","year":"2010","unstructured":"Fernandes N.V.; Guntipalli P.K.; Mo H.; d-\u03b4-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells. Anticancer Res 2010,30(12),4937-4944","journal-title":"Anticancer Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1097\/MPA.0b013e3181a20f9c","volume":"38","author":"Hussein D.","year":"2009","unstructured":"Hussein D.; Mo H.; d-\u03b4-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas 2009,38(4),e124-e136","journal-title":"Pancreas"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1006845120287","volume":"188","author":"Iliskovic N.","year":"1998","unstructured":"Iliskovic N.; Li T.; Khaper N.; Palace V.; Singal P.K.; Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress. Mol Cell Biochem 1998,188(1-2),161-166","journal-title":"Mol Cell Biochem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2017.10.022","volume":"114","author":"Zhong W.","year":"2018","unstructured":"Zhong W.; Systematic review of decision aids for the management of men with localized prostate cancer. Urology 2018,114,1-7","journal-title":"Urology"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","volume":"375","author":"Donovan J.L.","year":"2016","unstructured":"Donovan J.L.; Hamdy F.C.; Lane J.A.; Mason M.; Metcalfe C.; Walsh E.; Blazeby J.M.; Peters T.J.; Holding P.; Bonnington S.; Lennon T.; Bradshaw L.; Cooper D.; Herbert P.; Howson J.; Jones A.; Lyons N.; Salter E.; Thompson P.; Tidball S.; Blaikie J.; Gray C.; Bollina P.; Catto J.; Doble A.; Doherty A.; Gillatt D.; Kockelbergh R.; Kynaston H.; Paul A.; Powell P.; Prescott S.; Rosario D.J.; Rowe E.; Davis M.; Turner E.L.; Martin R.M.; Neal D.E.; Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 2016,375(15),1425-1437","journal-title":"N Engl J Med"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1021\/jf901619w","volume":"57","author":"Ho B.Y.","year":"2009","unstructured":"Ho B.Y.; Pan T.M.; The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells. J Agric Food Chem 2009,57(18),8258-8265","journal-title":"J Agric Food Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1021\/jf103652n","volume":"59","author":"Hsu L.C.","year":"2011","unstructured":"Hsu L.C.; Hsu Y.W.; Liang Y.H.; Kuo Y.H.; Pan T.M.; Anti-tumor and anti-inflammatory properties of ankaflavin and monaphilone A from monascus purpureus NTU 568. J Agric Food Chem 2011,59(4),1124-1130","journal-title":"J Agric Food Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0300-483X(00)00272-9","volume":"155","author":"Simonini G.","year":"2000","unstructured":"Simonini G.; Pignone A.; Generini S.; Falcini F.; Cerinic M.M.; Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology 2000,155(1-3),1-15","journal-title":"Toxicology"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2014.03.004","volume":"87","author":"Ciurleo R.","year":"2014","unstructured":"Ciurleo R.; Bramanti P.; Marino S.; Role of statins in the treatment of multiple sclerosis. Pharmacol Res 2014,87,133-143","journal-title":"Pharmacol Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.phrs.2014.03.001","volume":"88","author":"Ulivieri C.","year":"2014","unstructured":"Ulivieri C.; Baldari C.T.; Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases. Pharmacol Res 2014,88,41-52","journal-title":"Pharmacol Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","volume":"65","author":"Zhang F.L.","year":"1996","unstructured":"Zhang F.L.; Casey P.J.; Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 1996,65,241-269","journal-title":"Annu Rev Biochem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00005-010-0084-z","volume":"58","author":"Bartosik-Psujek H.","year":"2010","unstructured":"Bartosik-Psujek H.; Tabarkiewicz J.; Pocinska K.; Radej S.; Stelmasiak Z.; Rolinski J.; Immunomodulatory effects of IFN-beta and lovastatin on immunophenotype of monocyte-derived dendritic cells in multiple sclerosis. Arch Immunol Ther Exp (Warsz) 2010,58(4),313-319","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1523\/JNEUROSCI.4288-03.2004","volume":"24","author":"Giri S.","year":"2004","unstructured":"Giri S.; Nath N.; Smith B.; Viollet B.; Singh A.K.; Singh I.; 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J Neurosci 2004,24(2),479-487","journal-title":"J Neurosci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","volume":"73","author":"Negrotto L.","year":"2016","unstructured":"Negrotto L.; Farez M.F.; Correale J.; Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurol 2016,73(5),520-528","journal-title":"JAMA Neurol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2016.01.014","volume":"292","author":"Sun Y.","year":"2016","unstructured":"Sun Y.; Tian T.; Gao J.; Liu X.; Hou H.; Cao R.; Li B.; Quan M.; Guo L.; Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice. J Neuroimmunol 2016,292,58-67","journal-title":"J Neuroimmunol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.expneurol.2014.09.006","volume":"261","author":"Chan K.M.","year":"2014","unstructured":"Chan K.M.; Gordon T.; Zochodne D.W.; Power H.A.; Improving peripheral nerve regeneration: from molecular mechanisms to potential therapeutic targets. Exp Neurol 2014,261,826-835","journal-title":"Exp Neurol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nm1056","volume":"10","author":"Pearse D.D.","year":"2004","unstructured":"Pearse D.D.; Pereira F.C.; Marcillo A.E.; Bates M.L.; Berrocal Y.A.; Filbin M.T.; Bunge M.B.; cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 2004,10(6),610-616","journal-title":"Nat Med"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1527-3458.2001.tb00206.x","volume":"7","author":"Zhu J.","year":"2001","unstructured":"Zhu J.; Mix E.; Winblad B.; The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev 2001,7(4),387-398","journal-title":"CNS Drug Rev"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5551\/jat.RV16003","volume":"24","author":"Masuda D.","year":"2017","unstructured":"Masuda D.; Yamashita S.; Postprandial hyperlipidemia and remnant lipoproteins. J Atheroscler Thromb 2017,24(2),95-109","journal-title":"J Atheroscler Thromb"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11789-017-0086-z","volume":"12","author":"Hohenstein B.","year":"2017","unstructured":"Hohenstein B.; Lipoprotein(a) in nephrological patients. Clin Res Cardiol Suppl 2017,12(Suppl. 1),27-30","journal-title":"Clin Res Cardiol Suppl"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11886-016-0745-6","volume":"18","author":"Dallinga-Thie G.M.","year":"2016","unstructured":"Dallinga-Thie G.M.; Kroon J.; Bor\u00e9n J.; Chapman M.J.; Triglyceride-rich lipoproteins and remnants: targets for therapy? Curr Cardiol Rep 2016,18(7),67","journal-title":"Curr Cardiol Rep"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"830-9, W147-9.","DOI":"10.7326\/0003-4819-150-12-200906160-00006","author":"Becker D.J.","year":"2009","unstructured":"Becker D.J.; Red yeast rice for dyslipidemia in statin-intolerant patients: A randomized trial. Ann Intern Med, 2009(12),830-9, W147-9.","journal-title":"Ann Intern Med,"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","volume":"105","author":"Halbert S.C.","year":"2010","unstructured":"Halbert S.C.; French B.; Gordon R.Y.; Farrar J.T.; Schmitz K.; Morris P.B.; Thompson P.D.; Rader D.J.; Becker D.J.; Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol 2010,105(2),198-204","journal-title":"Am J Cardiol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/08923970902785253","volume":"31","author":"Roy A.","year":"2009","unstructured":"Roy A.; Pahan K.; Gemfibrozil, stretching arms beyond lipid lowering. Immunopharmacol Immunotoxicol 2009,31(3),339-351","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/FJC.0b013e3181624b22","volume":"51","author":"Hossain M.A.","year":"2008","unstructured":"Hossain M.A.; Tsujita M.; Gonzalez F.J.; Yokoyama S.; Effects of fibrate drugs on expression of ABCA1 and HDL biogenesis in hepatocytes. J Cardiovasc Pharmacol 2008,51(3),258-266","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.4049\/jimmunol.179.6.4142","volume":"179","author":"Jana M.","year":"2007","unstructured":"Jana M.; Jana A.; Liu X.; Ghosh S.; Pahan K.; Involvement of phosphatidylinositol 3-kinase-mediated up-regulation of I kappa B alpha in anti-inflammatory effect of gemfibrozil in microglia. J Immunol 2007,179(6),4142-4152","journal-title":"J Immunol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1161\/01.ATV.16.8.1052","volume":"16","author":"Jin F.Y.","year":"1996","unstructured":"Jin F.Y.; Kamanna V.S.; Chuang M.Y.; Morgan K.; Kashyap M.L.; Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2). Arterioscler Thromb Vasc Biol 1996,16(8),1052-1062","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1172\/JCI111879","volume":"75","author":"Saku K.","year":"1985","unstructured":"Saku K.; Gartside P.S.; Hynd B.A.; Kashyap M.L.; Mechanism of action of gemfibrozil on lipoprotein metabolism. J Clin Invest 1985,75(5),1702-1712","journal-title":"J Clin Invest"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1755-7682-3-34","volume":"3","author":"Zaki N.F.","year":"2010","unstructured":"Zaki N.F.; Sulaiman A.S.; Gillani W.S.; Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia. Int Arch Med 2010,3(1),34","journal-title":"Int Arch Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1515\/acph-2016-0043","volume":"66","author":"Zeman M.","year":"2016","unstructured":"Zeman M.; Vecka M.; Perl\u00edk F.; Sta\u0148kov\u00e1 B.; Hrom\u00e1dka R.; Tvrzick\u00e1 E.; \u0160irc J.; Hrib J.; \u017d\u00e1k A.; Pleiotropic effects of niacin: Current possibilities for its clinical use. Acta Pharm 2016,66(4),449-469","journal-title":"Acta Pharm"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11883-013-0325-9","volume":"15","author":"Chai J.T.","year":"2013","unstructured":"Chai J.T.; Digby J.E.; Choudhury R.P.; GPR109A and vascular inflammation. Curr Atheroscler Rep 2013,15(5),325","journal-title":"Curr Atheroscler Rep"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3810\/pgm.2014.05.2762","volume":"126","author":"Dayer-Berenson L.","year":"2014","unstructured":"Dayer-Berenson L.; Finckenor M.; Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia. Postgrad Med 2014,126(3),126-134","journal-title":"Postgrad Med"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1368-5031.2005.00601.x","volume":"59","author":"Cowie M.R.","year":"2005","unstructured":"Cowie M.R.; Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine\/atorvastatin single-pill therapy. Int J Clin Pract 2005,59(7),839-846","journal-title":"Int J Clin Pract"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1586\/erc.10.51","volume":"8","author":"Derosa G.","year":"2010","unstructured":"Derosa G.; Maffioli P.; Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients. Expert Rev Cardiovasc Ther 2010,8(6),835-843","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.apjtm.2017.08.020","volume":"10","author":"Farkhondeh T.","year":"2017","unstructured":"Farkhondeh T.; Samarghandian S.; Borji A.; An overview on cardioprotective and anti-diabetic effects of thymoquinone. Asian Pac J Trop Med 2017,10(9),849-854","journal-title":"Asian Pac J Trop Med"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jcp.25756","volume":"233","author":"Panahi Y.","year":"2018","unstructured":"Panahi Y.; Ahmadi Y.; Teymouri M.; Johnston T.P.; Sahebkar A.; Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. J Cell Physiol 2018,233(1),141-152","journal-title":"J Cell Physiol"},{"key":"ref=136","author":"Johnson-Arbor K.","year":"2017","unstructured":"Johnson-Arbor K.; Dubey R.; Doxorubicin, in StatPearls Treasure Island (FL) 2017","journal-title":"Treasure Island (FL)"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","volume":"818","author":"Renu K.","year":"2018","unstructured":"Renu K.; v G, A.; P B, T.P.; Arunachalam, S. Molecular mechanism of doxorubicin-induced cardiomyopathy - An update. Eur J Pharmacol 2018,818,241-253","journal-title":"Eur J Pharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.febslet.2012.11.019","volume":"587","author":"Arunachalam S.","year":"2013","unstructured":"Arunachalam S.; Tirupathi Pichiah P.B.; Achiraman S.; Doxorubicin treatment inhibits PPAR\u03b3 and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models. FEBS Lett 2013,587(2),105-110","journal-title":"FEBS Lett"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3109\/15376516.2012.692110","volume":"22","author":"Arunachalam S.","year":"2012","unstructured":"Arunachalam S.; Kim S.Y.; Kim M.S.; Yi H.K.; Yun B.S.; Lee D.Y.; Hwang P.H.; Adriamycin inhibits adipogenesis through the modulation of PPAR\u03b3 and restoration of adriamycin-mediated inhibition of adipogenesis by PPAR\u03b3 over-expression. Toxicol Mech Methods 2012,22(7),540-546","journal-title":"Toxicol Mech Methods"},{"key":"ref=140","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/795602","author":"Angsutararux P.","year":"2015","unstructured":"Angsutararux P.; Luanpitpong S.; Issaragrisil S.; Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative Stress. Oxid Med Cell Longev 2015","journal-title":"Oxid Med Cell Longev"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/fcp.12258","volume":"31","author":"Wang H.L.","year":"2017","unstructured":"Wang H.L.; Cui X.H.; Yu H.L.; Wu R.; Xu X.; Gao J.P.; Synergistic effects of polydatin and vitamin C in inhibiting cardiotoxicity induced by doxorubicin in rats. Fundam Clin Pharmacol 2017,31(3),280-291","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=142","first-page":"727","volume":"150","author":"Iliskovic N.","year":"1997","unstructured":"Iliskovic N.; Singal P.K.; Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol 1997,150(2),727-734","journal-title":"Am J Pathol"},{"key":"ref=143","first-page":"246","volume":"8","author":"Zhou X.","year":"2016","unstructured":"Zhou X.; Li Y.; Shi X.; Ma C.; An overview on therapeutics attenuating amyloid \u03b2 level in Alzheimer\u2019s disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels. Am J Transl Res 2016,8(2),246-269","journal-title":"Am J Transl Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s13760-016-0639-9","volume":"116","author":"Gupta A.","year":"2016","unstructured":"Gupta A.; Goyal R.; Amyloid beta plaque: a culprit for neurodegeneration. Acta Neurol Belg 2016,116(4),445-450","journal-title":"Acta Neurol Belg"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1096\/fj.201601309","volume":"31","author":"Area-Gomez E.","year":"2017","unstructured":"Area-Gomez E.; Schon E.A.; On the pathogenesis of Alzheimer\u2019s Disease: The MAM hypothesis. FASEB J 2017,31(3),864-867","journal-title":"FASEB J"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1021\/acs.jcim.7b00431","volume":"57","author":"Lockhart C.","year":"2017","unstructured":"Lockhart C.; Klimov D.K.; Cholesterol changes the mechanisms of A\u03b2 peptide binding to the DMPC bilayer. J Chem Inf Model 2017,57(10),2554-2565","journal-title":"J Chem Inf Model"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1021\/acs.biochem.7b00262","volume":"56","author":"Summers K.L.","year":"2017","unstructured":"Summers K.L.; Fimognari N.; Hollings A.; Kiernan M.; Lam V.; Tidy R.J.; Paterson D.; Tobin M.J.; Takechi R.; George G.N.; Pickering I.J.; Mamo J.C.; Harris H.H.; Hackett M.J.; A Multimodal spectroscopic imaging method to characterize the metal and macromolecular content of proteinaceous aggregates (\u201camyloid plaques\u201d). Biochemistry 2017,56(32),4107-4116","journal-title":"Biochemistry"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jinorgbio.2011.05.013","volume":"105","author":"Granzotto A.","year":"2011","unstructured":"Granzotto A.; Suwalsky M.; Zatta P.; Physiological cholesterol concentration is a neuroprotective factor against \u03b2-amyloid and \u03b2-amyloid-metal complexes toxicity. J Inorg Biochem 2011,105(8),1066-1072","journal-title":"J Inorg Biochem"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jff.2015.08.002","volume":"18","author":"Lee C.L.","year":"2015","unstructured":"Lee C.L.; Monascus-fermented monascin and ankaflavin improve the memory and learning ability in amyloid beta-protein intracerebroventricular-infused rat via the suppression of Alzheimer\u2019s disease risk factors. J Funct Foods 2015,18,387-399","journal-title":"J Funct Foods"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1002\/jnr.22503","volume":"88","author":"Asai M.","year":"2010","unstructured":"Asai M.; Iwata N.; Tomita T.; Iwatsubo T.; Ishiura S.; Saido T.C.; Maruyama K.; Efficient four-drug cocktail therapy targeting amyloid-\u03b2 peptide for Alzheimer\u2019s disease. J Neurosci Res 2010,88(16),3588-3597","journal-title":"J Neurosci Res"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0002-9149(99)80523-2","volume":"75","author":"Schrott H.G.","year":"1995","unstructured":"Schrott H.G.; Stein E.A.; Dujovne C.A.; Davidson M.H.; Goris G.B.; Oliphant T.H.; Phillips J.C.; Shawaryn G.G.; Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy. Am J Cardiol 1995,75(1),34-39","journal-title":"Am J Cardiol"},{"key":"ref=152","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/908539","author":"Le Lay S.","year":"2014","unstructured":"Le Lay S.; Simard G.; Martinez M.C.; Andriantsitohaina R.; Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxid Med Cell Longev 2014","journal-title":"Oxid Med Cell Longev"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1139\/cjpp-2016-0193","volume":"94","author":"Tunsophon S.","year":"2016","unstructured":"Tunsophon S.; Chootip K.; Comparative effects of piperine and simvastatin in fat accumulation and antioxidative status in high fat-induced hyperlipidemic rats. Can J Physiol Pharmacol 2016,94(12),1344-1348","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.lfs.2013.03.015","volume":"92","author":"Kesh S.B.","year":"2013","unstructured":"Kesh S.B.; Sikder K.; Manna K.; Das D.K.; Khan A.; Das N.; Dey S.; Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet-induced stress in mice. Life Sci 2013,92(17-19),938-949","journal-title":"Life Sci"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00253-011-3413-1","volume":"91","author":"Lee C.L.","year":"2011","unstructured":"Lee C.L.; Pan T.M.; Red mold fermented products and Alzheimer\u2019s disease: a review. Appl Microbiol Biotechnol 2011,91(3),461-469","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.amjmed.2017.05.013","volume":"130","author":"Dujovne C.A.","year":"2017","unstructured":"Dujovne C.A.; Red Yeast Rice Preparations: Are They Suitable Substitutions for Statins? Am J Med 2017,130(10),1148-1150","journal-title":"Am J Med"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/dta.1929","volume":"8","author":"Venhuis B.J.","year":"2016","unstructured":"Venhuis B.J.; van Hunsel F.; van de Koppel S.; Keizers P.H.; Jeurissen S.M.; De Kaste D.; Pharmacologically effective red yeast rice preparations marketed as dietary supplements illustrated by a case report. Drug Test Anal 2016,8(3-4),315-318","journal-title":"Drug Test Anal"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.fct.2015.06.009","volume":"83","author":"Gayathri L.","year":"2015","unstructured":"Gayathri L.; Dhivya R.; Dhanasekaran D.; Periasamy V.S.; Alshatwi A.A.; Akbarsha M.A.; Hepatotoxic effect of ochratoxin A and citrinin, alone and in combination, and protective effect of vitamin E: In vitro study in HepG2 cell. Food Chem Toxicol 2015,83,151-163","journal-title":"Food Chem Toxicol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.3390\/ijms10083338","volume":"10","author":"Chen C.C.","year":"2009","unstructured":"Chen C.C.; Chan W.H.; Inhibition of citrinin-induced apoptotic biochemical signaling in human hepatoma G2 cells by resveratrol. Int J Mol Sci 2009,10(8),3338-3357","journal-title":"Int J Mol Sci"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"7880","DOI":"10.1021\/jf301889q","volume":"60","author":"Hsu L.C.","year":"2012","unstructured":"Hsu L.C.; Hsu Y.W.; Liang Y.H.; Lin Z.H.; Kuo Y.H.; Pan T.M.; Protective effect of deferricoprogen isolated from Monascus purpureus NTU 568 on citrinin-induced apoptosis in HEK-293 cells. J Agric Food Chem 2012,60(32),7880-7885","journal-title":"J Agric Food Chem"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1021\/jf304015z","volume":"61","author":"Lee C.L.","year":"2013","unstructured":"Lee C.L.; Wen J.Y.; Hsu Y.W.; Pan T.M.; Monascus-fermented yellow pigments monascin and ankaflavin showed antiobesity effect via the suppression of differentiation and lipogenesis in obese rats fed a high-fat diet. J Agric Food Chem 2013,61(7),1493-1500","journal-title":"J Agric Food Chem"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ctim.2012.07.004","volume":"20","author":"Yang C.W.","year":"2012","unstructured":"Yang C.W.; Mousa S.A.; The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders. Complement Ther Med 2012,20(6),466-474","journal-title":"Complement Ther Med"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/archinternmed.2010.382","volume":"170","author":"Gordon R.Y.","year":"2010","unstructured":"Gordon R.Y.; Cooperman T.; Obermeyer W.; Becker D.J.; Marked variability of monacolin levels in commercial red yeast rice products: buyer beware! Arch Intern Med 2010,170(19),1722-1727","journal-title":"Arch Intern Med"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.2903\/j.efsa.2011.2304","volume":"9","year":"2011","unstructured":"EFSA Panel on Dietetic Products.Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL-cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924\/2006. EFSA J 2011,9(7),2304","journal-title":"EFSA J"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/160855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T21:25:18Z","timestamp":1693603518000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/160855\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":164,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019,9,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180330091933","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2019,9,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}